Endpoint Health
Jason is an accomplished start-up founder and executive with experience developing and commercializing disruptive products that tackle healthcare’s most urgent challenges. Jason co-founded and served as a board member of GeneWEAVE, a diagnostics company that developed rapid tests to detect and guide therapy choice for serious infections. Started in 2010, GeneWEAVE raised $25M in venture financing and was acquired by Roche in 2015. Prior to GeneWEAVE Jason worked at Lockheed Martin’s Aerospace and Logistics Services division.
Jason went on to co-found Endpoint Health, where he is currently a board member and CEO. He is an angel investor focused on pre-seed/seed stage healthcare companies with data, diagnostic, and therapeutic indications. Jason received an MBA from Cornell University.
This person is not in any offices
Endpoint Health
Endpoint Health's mission is to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology.